Mefloquine (previously marketed in the United States as Lariam®) is an antimalarial
medication with potent psychotropic potential. Severe psychiatric side effects due to mefloquine …

Obstetric use of the antimalarial drug mefloquine has historically been discouraged during
the first trimester and immediately before conception owing to concerns of potential fetal harm…

Intoxication with the antimalarial drug mefloquine (previously marketed as Lariam) is a
potentially life-threatening condition marked by changes in affect, behavior, cognition, and …

To the Editor I read with interest the report by Naito and colleagues describing successful
treatment of a case of progressive multifocal leukoencephalopathy with mefloquine (1). Their …

Given mounting evidence of a plausible biological mechanism by which mefloquine may
adversely affect the viability of the implanting embryo and of the developing placenta [10], the …

I read with interest the article by Schneiderman et al., 1 which examined associations
between self-reported mefloquine exposure and recent mental health symptoms among US …

“I was standing when I came to. Not lying down. And it wasn’ta gradual waking process. It
was darkness darkness darkness, then snap. Me. Now awake.” So begins David Stuart …

I read with interest the recent article by Osório and colleagues, 1 which employs principal
components analysis to examine associations between combat experiences and reported …

I read with interest the recent analysis by Eick-Cost and others, which examined associations
among US military personnel between various neurologic and psychiatric diagnoses and …

I refer to your correspondence from February 10, 2016 (Attachment 1), in which you advised
that a Working Group led by your department is examining issues related to malaria …